The Valley Desk

ArticleCancer immunology researchPublished

Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies

21 of 49 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
Cancer immunology research
Published
Subject terms
T-Lymphocytes; Cell Line, Tumor; Animals; Humans; Mice; Diacylglycerol Kinase; Immunotherapy, Adoptive; Xenograft Model Antitumor Assays; Female; Programmed Cell Death 1 Receptor; Receptors, Chimeric Antigen
PubMed ID
40506249
PubMed Central ID
PMC12402804
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal